Mixed Chimerism at Three Months after Allogeneic Hematopoietic Stem Cell Transplantation Is a Significant Predictor of Disease Relapse in High-Risk Acute Myeloid Leukemia Patients in First Complete Remission
Mauricette Michallet(Université Claude Bernard Lyon 1), Franck E. Nicolini(Hôpital Lyon Sud), Fiorenza Barraco(Hôpital Lyon Sud), Xavier Thomas(Hôpital Lyon Sud), Philippe Moskovtchenko, Hélène Labussière‐Wallet(Hospices Civils de Lyon), Mohamad Sobh(Ottawa Hospital), Isabelle Mollet, Valérie Mialou(Institut d’Hématologie et d’Oncologie Pédiatrique), Marie Balsat(Hôpital Claude Huriez), Caroline Lejeune(Hôpital Lyon Sud), Valérie Dubois(Établissement Français du Sang)
Cited by 1
Related Papers
Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
|The Lancet|2012|1k
Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials
|Journal of Clinical Oncology|2003|606
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
|Journal of Clinical Oncology|2009|562
Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial
|Journal of Clinical Oncology|2004|547